X0202 SCHEDULE 13G 0001716621 XXXXXXXX LIVE Common Stock, par value $0.0001 per share 06/18/2026 0001853070 Volato Group, Inc. 74349W302 1954 AIRPORT ROAD SUITE 124 CHAMBLEE GA 30341 Rule 13d-1(c) Catheter Precision, Inc. DE 2941176.00 0.00 2941176.00 0.00 2941176.00 7.5 CO Volato Group, Inc. 1954 AIRPORT ROAD, SUITE 124, CHAMBLEE, GEORGIA, 30341. Catheter Precision, Inc. 1670 Highway 160 West, Suite 205, Fort Mill, SC 29708 Delaware corporation Y Reference is hereby made to Rows 5?9 and 11 of the cover page of this Schedule 13G, which are incorporated herein by reference. As of June 18, 2026, Catheter Precision, Inc. (the "Reporting Person") acquired and beneficially owns 2,941,176 shares (the "Shares") of common stock, par value $0.0001 per share, of Volato Group, Inc. (NYSE American: SOAR) (the "Issuer"). The Shares were acquired by the Reporting Person pursuant to a Securities Purchase Agreement, dated as of June 7, 2026, by and between the Issuer and the Reporting Person (the "Purchase Agreement"), with the closing of the purchase occurring on June 18, 2026. The calculation of the percentage of beneficial ownership in Row 11 of the cover page of this Schedule 13G was derived from the Issuer's Form S-3 Registration Statement filed with the Securities and Exchange Commission on June 18, 2026, in which the Issuer stated that 39,336,982 shares of its common stock were outstanding after giving effect to the issuance of the Shares sold in the private placement of which the Reporting Person's purchase was a part. The information set forth in Item 4(a) herein is hereby incorporated by reference. The information set forth in Item 4(a) herein is hereby incorporated by reference. The information set forth in Item 4(a) herein is hereby incorporated by reference. The information set forth in Item 4(a) herein is hereby incorporated by reference. The information set forth in Item 4(a) herein is hereby incorporated by reference. Y N Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. None. Catheter Precision, Inc. /s/ Phillip Anderson 06/26/2026